Cresset Asset Management LLC Lowers Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Cresset Asset Management LLC trimmed its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 79.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,234 shares of the health services provider's stock after selling 83,430 shares during the quarter. Cresset Asset Management LLC's holdings in Teladoc Health were worth $202,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. Whipplewood Advisors LLC purchased a new stake in Teladoc Health in the 4th quarter valued at $29,000. Lindbrook Capital LLC grew its holdings in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after buying an additional 1,612 shares in the last quarter. Sterling Capital Management LLC grew its holdings in shares of Teladoc Health by 776.7% during the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after purchasing an additional 4,101 shares during the period. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Teladoc Health during the 4th quarter worth $60,000. Finally, Generali Investments Management Co LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth $64,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Evercore ISI lowered their price target on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a report on Thursday, May 1st. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Canaccord Genuity Group decreased their target price on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Citigroup decreased their target price on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research note on Friday, April 25th. Finally, Jefferies Financial Group decreased their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a research note on Monday, April 21st. Twelve research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Teladoc Health has an average rating of "Hold" and an average price target of $9.71.

Teladoc Health Stock Down 1.2%

TDOC stock traded down $0.09 during mid-day trading on Friday, reaching $6.82. The company had a trading volume of 4,118,390 shares, compared to its average volume of 6,248,706. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company has a market capitalization of $1.20 billion, a price-to-earnings ratio of -1.18 and a beta of 1.82. The firm has a fifty day simple moving average of $7.42 and a 200 day simple moving average of $9.29.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.58% of the stock is currently owned by company insiders.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.